Who We Are

We See the Big Picture

As a leader of specialized biotech events, we take pride in connecting today’s emerging leadership with investors and stakeholders through focused networking conferences, exclusive events, and more. This leads to potential investment opportunities, strategic collaborations, and a deeper understanding of the biotech landscape.

It’s our mission to generate genuine enthusiasm about promising biotechnology companies and examine and address the opportunities and challenges facing the biopharmaceutical industry.

Our Past. Our Present. Our Future.

BCS 304 scaled

For over two decades, Demy-Colton has committed itself to understanding the complexities and strategic challenges that face the biopharmaceutical industry.

We have a proven track record of bringing together C-suite management, key advisors, and stakeholders to explore mutually beneficial opportunities in the biotech sector. Our highly targeted events and our dedication to peer-to-peer exposure foster the growth of next-wave biotech leaders. By carefully targeting and selecting attendees, we ensure more meaningful networking relationships and potential collaborations.

BCS 304 scaled

A Team of Leaders

Great teams are made up of inspired individuals and innovative thinkers who share a common goal. At Demy-Colton, our goal is to meet the unique needs of leaders in the biotech and life sciences industries.

Who We Are1

Sara Jane Demy, Founder & CEO

Sara is one of the most influential networkers and connectors in the life sciences industry. As the CEO and founder of Demy-Colton, she brings decades of experience in launching, developing, and shaping high-profile investor and business development conferences in the healthcare industry.

In 2008, Sara founded Demy-Colton, a company dedicated to facilitating growth in life sciences and digital medicine, through the creation of compelling industry conferences and virtual events. She is committed to fostering the support and advancement of entrepreneurs and companies that are focused on bringing innovative new therapies to improve patient lives and care.

Sara is a fierce advocate for diversity in all forms and has made a commitment to fostering inclusion in all Demy-Colton events. As one of the founders of Biotech Showcase, she led the movement on calling out “manels” and made a commitment to ensure gender diversity on all panels at every event.

Prior to founding Demy-Colton, Sara was Vice President for Business Development and Investor Relations at the Biotechnology Innovation Organization (BIO). During her tenure, she led the launch of the BIO CEO & Investor Conference, BIO Investor Forum, BIO Asia, regional investor forums, the Business Forum at BIO’s annual meeting. She expanded BIO-Europe, helped launch BioEurope Spring and BioEquity, and was part of the team during the development of the partnering system, which has become an essential component of all biopharma business development meetings.

Sara was also Director for Foreign Investment at the Empire State Development Corporation, which has a mission of making New York a location of choice for international companies. One of her clients was Beecham Pharmaceuticals, now a part of GSK, which was looking to build a 600-person ethical research facility. It was through her work with Beecham that she was introduced to the then nascent biopharma industry and ultimately, BIO. Sara holds a bachelor’s degree in international relations from the University at Albany.

Lila Taylor scaled e1708342673583

Lila Taylor, Chief Business Officer

Since 2015, Lila has played an integral role in shaping and expanding Demy-Colton events and products. She seamlessly builds relationships with biotechnology and pharmaceutical companies, industry stakeholders, and venture capitalists to shape innovative conferences worldwide, and continues to seek out the most promising biotech companies from around the world to present at such events.

Her science expertise incorporates experience as Director of Alliance Management at KineMed, Inc., a biotechnology company specializing in clinical proteomic biomarkers, and as former Head of the Presenter Selection Committee and Client Manager at Technology Vision Group LLC, a producer of international biotechnology business development and investment conferences.

Dan Ruiz e1708342457796

Dan Ruiz, Chief Operating Officer

Dan comes to Demy-Colton with a rich well of diverse experience. His career is one in which business development, global growth, and customer satisfaction are paramount. His executive tenure at AT&T included planning and executing the company’s expansion into Europe, Asia, and the Middle East, which was instrumental in developing the brand globally. As the Chief Marketing Officer of a new internet venture, Dan led the firm’s effort to introduce e-commerce to a $200 billion industry and bellwether measure for the US economy. A successful marketing and public relations program helped establish that venture as the leading pioneer in this industry.

Dan’s experience in real estate, banking, and airline sectors rounds out his capabilities in marketing, sales, and business development. His academic background includes undergraduate degrees in business and foreign languages and an MBA from Columbia University.

Linda Burke

Linda Burke, Director, Corporate Development & Communications

As a member of the Demy-Colton team since 2011, Linda has supported all areas of event planning, promotion, and execution. She leverages her experience in the healthcare industry (including weight and healthcare management) and the financial services industry to support Demy-Colton’s operations and growth. Linda also manages Demy-Colton’s websites and sponsor relationships. Linda received an undergraduate degree in sociology and a master’s degree in public affairs from Baruch College.

Lawrence Joseph

Lawrence Joseph, Director, Operations

Since 2008, Lawrence has been responsible for managing client relations and operations. His implementation of events is tightly linked to a personable and professional attitude developed from more than a decade in the hospitality industry. At Demy-Colton, his responsibilities involve event operations and execution including communications with presenters, scheduling of presentations, onsite presentation management, and deployment of Networking2, Demy-Colton’s partnering system.

Sara Pinto

Sara Pinto, Managing Director, Program Development

Sara joined the Demy-Colton team in 2019 and is responsible for program planning, execution and implementation across Demy-Colton’s entire suite of events. Sara brings over 20 years of experience in conference and events planning (in-person and digital) for executives and the C-suite community within the professional and scholarly publishing industry. Sara is a graduate of Oxford Brookes University (UK) and holds a joint bachelor’s degree in publishing and English language, literature, and discourse.

Upcoming Events

Join the best in biotech and discover the next level of must-attend investor, business development, and C-level events.

DemyColton EventLogo btcseu 1
May 27-29, 2024
DemyColton EventLogo btcsusa 1
July 15-17, 2024
DemyColton EventLogo bf e1706861379941 1
October 28-30, 2024
DemyColton EventLogos bts
January 13-15, 2025
DemyColton EventLogos dms
January 13-15, 2025
DemyColton EventLogos seed
January 13-15, 2025
DemyColton EventLogo vs 1
Multiple Dates